Israeli vaccine is safe and effective

Israeli vaccine is safe and effective

NRx Pharmaceuticals has announced that it will continue its plans to launch the next phase of trials for Israel's BriLife vaccine.

The Jerusalem Post reports.

On Monday, it was announced that the independent data security monitoring board overseeing the Phase II trial has completed its analysis with a positive result.

According to the company, the report is expected in the coming days. … NRx received recommendations for the design of its study from the European Medicines Agency and the World Health Organization. The study is expected to be conducted in Israel and Georgia.

& quot; We are delighted to move forward with the multinational BriLife trial at a time when the immunity created by the widespread adoption of first-generation vaccines is increasingly being challenged danger from new strains of coronavirus, '' said NRx CEO Jonathan Javitt.

Add a Comment

Your email address will not be published.